XGN

EXAGEN INC

XGN·30068X103·US·Common Stock·Healthcare - Diagnostics & Research-13D/G

XGN (EXAGEN INC) is held by 36 institutional investors as of Q2 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($2.8M), SILVERCREST ASSET MANAGEMENT GROUP LLC ($2.4M), JANE STREET GROUP, LLC ($1.5M). Net institutional sentiment: Mixed.

36
Holders
$17.2M
Total Value
39% (36)
Consensus
14 buying - 22 selling
13F: Insider & Congress: Updated regularly
XGN

Smart Money Verdict

View all
Loading verdict
Held by 36 funds

Who's Trading

Source dates: Price Aug 27, 2026 · Insiders Mar 4, 2026 · Activists May 27, 2026 · Congress none

ActivistPUParian Ultreia LP5.3%May 27, 2026
ActivistCJChernett Jorey9.9%May 20, 2026
InsiderAJABALLI JOHNSell $57KMar 3, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Decreased
612,832(-9.7%)$2.8M0.0%+123.62%
0
Decreased
514,761(-4.3%)$2.4M0.0%-42.88%
0
Increased
322,502(+36.2%)$1.5M0.0%+12.52%
33
Increased
306,965(+145.1%)$1.4M0.0%+84.72%
41
Increased
306,703(+1023.9%)$1.4M0.0%+59.33%
41
Decreased
195,000(-50.7%)$906,7500.0%-26.42%
0
Increased
185,654(+3.8%)$863,8730.0%-32.23%
18
Increased
167,292(+29.0%)$777,9080.0%+82.32%
31
Increased
142,625(+13.3%)$663,2060.0%+32.04%
19
Decreased
111,948(-53.8%)$520,5580.0%+62.72%
0
Decreased
109,005(-55.4%)$506,8730.0%+64.01%
0
Decreased
108,993(-62.3%)$506,8170.0%+81.91%
0
Increased
108,649(+11.7%)$505,2180.0%+115.61%
27
Unchanged
71,256$331,3400.0%+45.21%
0
Unchanged
62,571$290,9860.0%+146.84%
0
Decreased
59,992(-62.0%)$278,9630.0%-9.14%
0
Decreased
52,082(-57.1%)$242,1810.0%+11.39%
0
Increased
49,712(+43.8%)$231,1610.0%+40.98%
31
Decreased
39,600(-80.5%)$184,1400.0%+48.03%
0
Increased
39,513(+5.2%)$183,7350.0%-36.93%
16

Showing 1-20 of 43

1 / 3
XGNXGNEXAGEN INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used